Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness). by Ann Logan (9361)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

The relative duration and distance in each time gap. by Tomohiro Gonjo (8825780)

Adverse events and treatment interruptions. by Nicola Squillace (691608)

Subjects:

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

Characteristics of the participants (mean ± SD): Age and biomarkers. by Chul-young Bae (14709766)

Subjects:

Characteristics of the participants (mean ± SD): Lifestyle (numeric). by Chul-young Bae (14709766)

Subjects:

Mean±SD of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Key safety measures including adverse events. by Anuja Dokras (8679261)

“…Waist circumference (mean change (MC) −2.23 cm; 95% CI [−3.98, −0.49]; <i>p</i> = 0.01), BMI (MC −0.49 kg/m²; 95% CI [−0.88, −0.10[; <i>p</i> = 0.01), and android fat mass measured by DXA (MC −167 g; 95% CI [−264, −71[; <i>p</i> < 0.001) decreased in the COCP group over the study period whilst there was no statistically significant changes in these parameters in the metformin only group when compared to baseline.. …”

Mean, SD, and Pearson correlations between SWB scales scores. by August Håkan Nilsson (12937056)

Subjects:

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

<i>SOX2</i> knockdown decreases OSCC cell migration and EMT. by Alessandro Sacco (8799386)

Adverse event list. by Stefan Halbherr (21353882)

Subjects:

Laser irradiation in the PBMT group. by Katayoon Montazeri (18389243)

Subjects:

Between-groups comparison of GIN and PPI values in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Diagram of methods. by Katayoon Montazeri (18389243)

Subjects:

Doublecortin (DCX) expression in 3 brain regions (coronal sections) in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects:

PBMT parameters. by Katayoon Montazeri (18389243)

Subjects:

Fig 4 - by Katayoon Montazeri (18389243)

Subjects:

Bar graphs of DCX expression evaluated in three brain regions in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects: